Overview

A Pilot Study of Thermodox and MR-HIFU for Treatment of Relapsed Solid Tumors

Status:
Not yet recruiting
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
This is a pilot study of LTLD with MR-HIFU hyperthermia followed by ablation in subjects with refractory/relapsed solid tumors.
Phase:
Phase 2
Details
Lead Sponsor:
Children's National Research Institute
Treatments:
Doxorubicin
Liposomal doxorubicin